PT DIAGNOS LABORATORIUM UTAMA TBK

Highlights PT Diagnos Laboratorium Utama Tbk

Equities

DGNS

ID1000158702

End-of-day quote INDONESIA S.E. Other stock markets 03:30:00 21/05/2024 am IST			5-day change	1st Jan Change
254 ^IDR	-0.78%		-3.05%	+3.25%

04/03	PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	04/03	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	31/23/31	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	03/23/03	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022	21/22/21	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Half Year Ended June 30, 2022	22/22/22	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022	18/22/18	CI
PT Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Full Year Ended December 31, 2021	05/22/05	CI
Pt Diagnos Laboratorium Utama Tbk Reports Earnings Results for the Half Year Ended June 30, 2021	09/21/09	CI
PT Diagnos Laboratorium Utama Tbk has completed an IPO in the amount of IDR 50 billion.	15/21/15	CI
PT Diagnos Laboratorium Utama Tbk has filed an IPO.	14/20/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW